Quarterly report pursuant to Section 13 or 15(d)

REVERSE RECAPITALIZATION - Additional Information (Detail)

v3.22.2
REVERSE RECAPITALIZATION - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Millions
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2022
Reverse Recapitalization [Line Items]      
Common stock, shares outstanding (in shares) 72,027,743 71,810,419 76,239,989
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001 $ 0.0001
Warrants outstanding (in shares)   8,911,744  
Increase in cash, net of transactions costs paid   $ 63.2  
Gross proceeds from PIPE   225.0  
Payments to preferred shareholders   229.9  
Transactions costs related to business combination   24.2  
Additional paid-in capital      
Reverse Recapitalization [Line Items]      
Transactions costs related to business combination $ 24.1    
Interfusion B.V. and T-Fone B.V.      
Reverse Recapitalization [Line Items]      
Repayment of outstanding related party loans   1.6  
UBS      
Reverse Recapitalization [Line Items]      
Repaid the senior secured revolving credit facility   25.0  
Backstop Notes      
Reverse Recapitalization [Line Items]      
Proceeds from backstop notes   95.1  
CTAC      
Reverse Recapitalization [Line Items]      
Proceeds from business combination, after redemptions   $ 20.0  
CTAC Shareholders      
Reverse Recapitalization [Line Items]      
Shares redeemed (in shares)   22,240,970  
Price per share of shares redeemed (in dollars per share)   $ 10.00  
PIPE Investors      
Reverse Recapitalization [Line Items]      
Shares issued (in shares)   22,500,000  
Price per share of shares issued (in dollars per share)   $ 10.00  
Public stockholders      
Reverse Recapitalization [Line Items]      
Common stock issued pursuant to acquisition (in shares)   10,356,593